BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Cao JX, You J, Wu LH, Luo K, Wang ZX. Clinical efficacy analysis of mesenchymal stem cell therapy in patients with COVID-19: A systematic review. World J Clin Cases 2022; 10(27): 9714-9726 [PMID: 36186213 DOI: 10.12998/wjcc.v10.i27.9714]
URL: https://www.wjgnet.com/2307-8960/full/v10/i27/9714.htm
Number Citing Articles
1
Al-Anazi Khalid Ahmed. Update on the Clinical Applications of Mesenchymal Stem CellsJournal of Stem Cell Therapy and Transplantation 2023; 7(1): 043 doi: 10.29328/journal.jsctt.1001034
2
Seyyed Mohammad Matin Alavi-Dana, Yazdan Gholami, Mohammadreza Meghdadi, Mohammad Saleh Fadaei, Vahid Reza Askari. Mesenchymal stem cell therapy for COVID-19 infectionInflammopharmacology 2024; 32(1): 319 doi: 10.1007/s10787-023-01394-8
3
Gaurav Gupta, Md Sadique Hussain, Riya Thapa, Rajiv Dahiya, Debarshi Kar Mahapatra, Asif Ahmad Bhat, Neelam Singla, Vetriselvan Subramaniyan, Sushama Rawat, Vikas Jakhmola, Roshan S, Kamal Dua. Hope on the horizon: Wharton's jelly mesenchymal stem cells in the fight against COVID-19Regenerative Medicine 2023; 18(9): 675 doi: 10.2217/rme-2023-0077
4
Al-Anazi Khalid A, Al-Ansari Rehab Y . Update on the Use of Mesenchymal Stem Cells in the Treatment of Various Infectious Diseases Including COVID-19 InfectionJournal of Stem Cell Therapy and Transplantation 2023; 7(1): 034 doi: 10.29328/journal.jsctt.1001033